<DOC>
	<DOCNO>NCT00344253</DOCNO>
	<brief_summary>The purpose study investigate interferon beta superior standard treatment Methotrexate treatment intermediate uveitis macular edema .</brief_summary>
	<brief_title>Randomized , Controlled Trial Test Efficacy Interferon Beta Treatment Intermediate Uveitis</brief_title>
	<detailed_description>Deuter et al first show anti-edematous effect interferon alpha inflammatory macular edema ( Deuter C. M. E. , Kötter I. , Günaydin I. , Zierhut M. Treatment Cystoid Macular Oedema Behçet 's Disease Interferon Alfa-2a , Retina , press ) . In interventional , multi-centric pilot-study could demonstrate positive effect interferon beta ED associate uveitis , especially reduce macular edema . Undesired effect treatment observe . Thus want test efficacy safety interferon beta compare standard treatment methotrexate prospective , clinically control trial patient suffer intermediate uveitis inflammatory macular edema either associate ED systemic disease association , i.e . primary uveitis . .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Intermediate</mesh_term>
	<mesh_term>Pars Planitis</mesh_term>
	<mesh_term>Encephalomyelitis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<criteria>Male female patient age 18 Active uni bilateral noninfectious intermediate uveitis least 1 year duration Visual acuity bad eye least 0.1 ( 20/200 ) maximally 0.6 ( 20/30 ) cause macular edema , define foveal thickness ≥ 250 µm Either primary uveitis diagnosis Multiple Sclerosis Previous treatment oral corticosteroid dose 0.5 mg per kg bodyweight prednisone equivalent without sufficient success Previous treatment immunosuppressive drug facultative Exclusively anterior uveitis Absence macular edema Optic nerve atrophy neuritis nervi optici Perior intraocular injection corticosteroid previous 3 month Allergies interferon Depression diagnose psychiatrist Hepatic disease Infectious Uveitis Other autoimmune disease MS Pregnancy , Lactation Lack reliable contraception Patients metabolic , psychiatric neoplastic disease Active disease like asthma , psoriasis inflammatory bowel disease treat corticosteroid primary secondary immune deficiency Tuberculosis infectious lung disease Hepatitis B C Life vaccination trial duration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>Macular Edema</keyword>
	<keyword>Interferon</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Encephalomyelitis disseminata ( ED )</keyword>
</DOC>